On October 18^th, 2019, in the signing ceremony “Promoting biomedical industry key projects of Lin-gang Special Area in China (Shanghai) Pilot Free Trade Zone” and the opening ceremony of Lin-gang Special Area Life Science Park, Belief BioMed became one of the first batch of 15 key projects successfully signed.

Belief BioMed plans to invest more than 1 billion RMB in Lin-gang to build a comprehensive center integrating manufacturing, quality control, office and other functions, in line with NMPA, FDA, EU and other cGMP standards of gene therapy drug research and production.  Leveraging the policy superiority of Lin-gang Special Area, the company will build an industry-academia-research development model integrating scientific research, clinical trials and medical services, to carry out R&D projects and drug production ranging from the front-end screening of adeno-associated virus gene therapy vectors（AAV）, production process optimization, GMP production, clinical quality control standards to clinical studies, etc.

With this strategic deployment in Lin-gang, Belief BioMed is to firmly seize the opportunity of rapid development of biomedical industry, realize a leapfrogged growth, and forge a world-class international gene therapy enterprise.